Evidence map›Paper›PMID 27798056›Full record

ReviewHeart (British Cardiac Society)2017

Computational modelling for congenital heart disease: how far are we from clinical translation?

Giovanni Biglino, Claudio Capelli, Jan Bruse, Giorgia M Bosi, Andrew M Taylor, Silvia Schievano

Open access · hybridAbstract readReview
In one paragraph

Review in Heart (British Cardiac Society), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Postnatal pulmonary artery development from transcript to tissue.Journal of the Royal Society, Interface · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Automatic segmentation of the great arteries for computational hemodynamic assessment.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Giovanni BiglinoBristol Heart Institute, School of Clinical Sciences, University of Bristol, Bristol, UK.
Claudio CapelliCardiorespiratory Unit, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.
Jan BruseCardiorespiratory Unit, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.
Giorgia M BosiCardiorespiratory Unit, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.
Andrew M TaylorCardiorespiratory Unit, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.
Silvia SchievanoCardiorespiratory Unit, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust · GBUniversity College London · GBBristol Royal Infirmary · GB

Funding

British Heart Foundation FS/09/008/26431British Heart Foundation FS/13/11/30056
6 · The paper itself

Abstract

Computational models of congenital heart disease (CHD) have become increasingly sophisticated over the last 20 years. They can provide an insight into complex flow phenomena, allow for testing devices into patient-specific anatomies (pre-CHD or post-CHD repair) and generate predictive data. This has been applied to different CHD scenarios, including patients with single ventricle, tetralogy of Fallot, aortic coarctation and transposition of the great arteries. Patient-specific simulations have been shown to be informative for preprocedural planning in complex cases, allowing for virtual stent deployment. Novel techniques such as statistical shape modelling can further aid in the morphological assessment of CHD, risk stratification of patients and possible identification of new 'shape biomarkers'. Cardiovascular statistical shape models can provide valuable insights into phenomena such as ventricular growth in tetralogy of Fallot, or morphological aortic arch differences in repaired coarctation. In a constant move towards more realistic simulations, models can also account for multiscale phenomena (eg, thrombus formation) and importantly include measures of uncertainty (ie, CIs around simulation results). While their potential to aid understanding of CHD, surgical/procedural decision-making and personalisation of treatments is undeniable, important elements are still lacking prior to clinical translation of computational models in the field of CHD, that is, large validation studies, cost-effectiveness evaluation and establishing possible improvements in patient outcomes.

Indexed as

Models, CardiovascularBioengineeringComputer SimulationHeart Defects, CongenitalHumansPatient-Specific ModelingProstheses and ImplantsTranslational Research, Biomedical

Identifiers

PMID27798056
PMCPMC5284484
OpenAlexW2532627760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.